Global Screening for Liver Cancer Market Growth (Status and Outlook) 2025-2031

The global Screening for Liver Cancer market size is predicted to grow from US$ 10360 million in 2025 to US$ 15970 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

Globally, liver cancer is one of the leading causes of cancer-related deaths. According to the American Cancer Society, the incidence of liver cancer has tripled since the 1980s, and the death rate has now doubled. In the United States, about 41,260 new cases are expected to be diagnosed, while about 30,520 deaths from liver cancer are expected, according to 2022 cancer statistics. The global prevalence of liver cancer and the continuous exposure of related populations to risk factors will rapidly drive the screening and diagnostics market.

ReportPrime's newest research report, the “Screening for Liver Cancer Industry Forecast” looks at past sales and reviews total world Screening for Liver Cancer sales in 2024, providing a comprehensive analysis by region and market sector of projected Screening for Liver Cancer sales for 2025 through 2031. With Screening for Liver Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Screening for Liver Cancer industry.

This Insight Report provides a comprehensive analysis of the global Screening for Liver Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Screening for Liver Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Screening for Liver Cancer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Screening for Liver Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Screening for Liver Cancer.

This report presents a comprehensive overview, market shares, and growth opportunities of Screening for Liver Cancer market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Hematology Test
• Imaging Test

Segmentation by Application:

• Hospital
• Clinic
• Other

Market by Region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Company's Coverage:

• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• Berry Oncology
• New Horizon Health
• BGI
• GTH.O
• Livzon
• BNR.O
• SingLera
• Fujifilm Medical Systems U.S.A., Inc.
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers
• BD
• Illumina, Inc.
• Epigenomics AG

Key Questions Addressed in this Report: